首页/数据集/tumor immuno-regulation of Lynch syndrome

tumor immuno-regulation of Lynch syndrome

NIAID Data Ecosystem2026-03-12 收录

Lynch综合征免疫微环境

肿瘤新抗原

数据链接：

https://www.ncbi.nlm.nih.gov/sra/SRP287563 数据链接链接失效反馈

官方服务：

资源简介：

tumor immune signatures and neoantigen discovery in patients of Lynch syndrome

应用场景：

创建时间：

2020-10-26

肿瘤新抗原

过继性T细胞治疗

Recurrent neoepitopes are cancer-specific antigens common among groups of patients and therefore ideal targets for adoptive T cell therapy. The neoepitope FSGEYIPTV carries the Rac1P29S amino acid cha

NIAID Data Ecosystem30

Supplementary Table 2 from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

肿瘤新抗原

免疫治疗响应评估

Characterization of tier 1 mutations identified in WHIM30 through NSG.

Figshare2017-07-01 更新20

Supplementary Data from A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8 + T-cell Responses, Impacting Tumor Challenge

肿瘤新抗原

T细胞免疫应答

TC1, LLC and ID8 neoantigen list

NIAID Data Ecosystem00

RNA-seq consisting of FASTQ paired-end reads from cancer samples

肿瘤新抗原

癌症免疫治疗

Efforts to precisely identify tumor human leukocyte antigen presented peptides (HLAp) capable of mediating T cell based tumor rejection still face important challenges. Recent reports suggest that non

NIAID Data Ecosystem20

Supplementary Data from A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge

肿瘤新抗原

CD8+T细胞免疫

TC1, LLC and ID8 neoantigen list

Figshare2019-02-01 更新10